Javascript must be enabled to continue!
Measurement of peak esophageal luminal cross‐sectional area utilizing nadir intraluminal impedance
View through CrossRef
AbstractBackgroundMultichannel intraluminal impedance (MII) is currently used to monitor gastroesophageal reflux and esophageal bolus clearance. We describe a novel methodology to measure maximal luminal cross‐sectional area (CSA) during bolus transport from MII measurements.MethodsStudies were conducted in‐vitro (test tubes) and in‐vivo (healthy subjects). Concurrent MII, high resolution manometry, and intraluminal ultrasound (US) images were recorded 7‐cm above the lower esophageal sphincter. Swallows with two concentrations of saline, 0.1 and 0.5 N, of bolus volumes 5, 10, and 15 cc were performed. The CSA was estimated by solving two algebraic Ohm's law equations, resulting from the two saline solutions. The CSA calculated from impedance method was compared with the CSA measured from the intraluminal US images.Key ResultsThe CSA measured in duplicate from B‐mode US images showed a mean difference between the two manual delineations to be near zero, and the repeatability coefficient was within 7.7% of the mean of the two CSA measurements. The calculated CSA from the impedance measurements strongly correlated with the US measured CSA (R2 ≅ 0.98). A detailed statistical analysis of the impedance and US measured CSA data indicated that the 95% limits of agreement between the two methods ranged from −9.1 to 13 mm2. The root mean square error of the two measurements was 4.8% of the mean US‐measured CSA.Conclusions & InferencesWe describe a novel methodology to measure peak esophageal luminal CSA from the nadir impedance during peristalsis. Further studies are needed to determine if it is possible to measure patterns of luminal distension during peristalsis across the entire length of the esophagus from the MII recordings.
Title: Measurement of peak esophageal luminal cross‐sectional area utilizing nadir intraluminal impedance
Description:
AbstractBackgroundMultichannel intraluminal impedance (MII) is currently used to monitor gastroesophageal reflux and esophageal bolus clearance.
We describe a novel methodology to measure maximal luminal cross‐sectional area (CSA) during bolus transport from MII measurements.
MethodsStudies were conducted in‐vitro (test tubes) and in‐vivo (healthy subjects).
Concurrent MII, high resolution manometry, and intraluminal ultrasound (US) images were recorded 7‐cm above the lower esophageal sphincter.
Swallows with two concentrations of saline, 0.
1 and 0.
5 N, of bolus volumes 5, 10, and 15 cc were performed.
The CSA was estimated by solving two algebraic Ohm's law equations, resulting from the two saline solutions.
The CSA calculated from impedance method was compared with the CSA measured from the intraluminal US images.
Key ResultsThe CSA measured in duplicate from B‐mode US images showed a mean difference between the two manual delineations to be near zero, and the repeatability coefficient was within 7.
7% of the mean of the two CSA measurements.
The calculated CSA from the impedance measurements strongly correlated with the US measured CSA (R2 ≅ 0.
98).
A detailed statistical analysis of the impedance and US measured CSA data indicated that the 95% limits of agreement between the two methods ranged from −9.
1 to 13 mm2.
The root mean square error of the two measurements was 4.
8% of the mean US‐measured CSA.
Conclusions & InferencesWe describe a novel methodology to measure peak esophageal luminal CSA from the nadir impedance during peristalsis.
Further studies are needed to determine if it is possible to measure patterns of luminal distension during peristalsis across the entire length of the esophagus from the MII recordings.
Related Results
The analysis on Tiam2 for expression in esophageal carcinoma: A descriptive study
The analysis on Tiam2 for expression in esophageal carcinoma: A descriptive study
Rationale:
To investigate T lymphoma invasion and metastasis inducing factor 2 (Tiam2) protein for expression in esophageal carcinoma and relationship with clinical fea...
EPD Electronic Pathogen Detection v1
EPD Electronic Pathogen Detection v1
Electronic pathogen detection (EPD) is a non - invasive, rapid, affordable, point- of- care test, for Covid 19 resulting from infection with SARS-CoV-2 virus. EPD scanning techno...
The slope associated with nadir prostate‐specific antigen is prognostically significant in men with hormone‐sensitive prostate cancer after primary androgen deprivation therapy
The slope associated with nadir prostate‐specific antigen is prognostically significant in men with hormone‐sensitive prostate cancer after primary androgen deprivation therapy
AbstractBackgroundPrognostic indicators based on the initial prostate‐specific antigen (PSA) levels, nadir PSA, and time to PSA nadir were calculated to evaluate prognosis after pr...
PSA Nadir and Time to PSA Nadir Following Androgen Deprivation Therapy are the Predictors for Castration-Resistant Prostate Cancer in Patients with Metastatic Prostate Cancer
PSA Nadir and Time to PSA Nadir Following Androgen Deprivation Therapy are the Predictors for Castration-Resistant Prostate Cancer in Patients with Metastatic Prostate Cancer
Purpose: To evaluate the influence of nadir prostate-specific antigen (PSA) level and time to PSA nadir following androgen deprivation therapy (ADT)on disease progression of castra...
022. TREATMENT EXPERIENCE OF ESOPHAGEAL FISTULA INDUCED BY NEOADJUVANT THERAPY IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA: A SINGLE-CENTER EXPERIENCE
022. TREATMENT EXPERIENCE OF ESOPHAGEAL FISTULA INDUCED BY NEOADJUVANT THERAPY IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA: A SINGLE-CENTER EXPERIENCE
Abstract
Background
Esophageal squamous cell carcinoma (ESCC) is typically treated with neoadjuvant therapy followed by esophage...
ÖZOFAGUS ATREZİLİ YENİDOĞANLARDA ANESTEZİK RİSKLER, MORBİDİTE VE MORTALİTE
ÖZOFAGUS ATREZİLİ YENİDOĞANLARDA ANESTEZİK RİSKLER, MORBİDİTE VE MORTALİTE
Giriş:
Özofagus atrezisi (ÖA), özofagusun proksimal ve distal bölümlerinin bağlantısının olmamasıdır ve 3000-4500 canlı
doğumda bir görülür. Özofagus atrezisi ve trakeoözofageal f...
O15 ESOPHAGEAL MOTILITY OF LUNG TRANSPLANT RECIPIENTS DIAGNOSED WITH SYSTEMIC CONNECTIVE TISSUE DISORDER: A SINGLE-CENTER EXPERIENCE
O15 ESOPHAGEAL MOTILITY OF LUNG TRANSPLANT RECIPIENTS DIAGNOSED WITH SYSTEMIC CONNECTIVE TISSUE DISORDER: A SINGLE-CENTER EXPERIENCE
Abstract
Aim
To examine the esophageal motility of lung transplant recipients diagnosed with systemic connective tissue disorder...

